347 related articles for article (PubMed ID: 10825124)
1. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis.
Shi Q; Xiong Q; Wang B; Le X; Khan NA; Xie K
Cancer Res; 2000 May; 60(10):2579-83. PubMed ID: 10825124
[TBL] [Abstract][Full Text] [Related]
2. Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase.
Wei D; Richardson EL; Zhu K; Wang L; Le X; He Y; Huang S; Xie K
Cancer Res; 2003 Jul; 63(14):3855-9. PubMed ID: 12873972
[TBL] [Abstract][Full Text] [Related]
3. Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase.
Wang B; Xiong Q; Shi Q; Le X; Xie K
Oncogene; 2001 Oct; 20(47):6930-7. PubMed ID: 11687972
[TBL] [Abstract][Full Text] [Related]
4. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K
Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG
Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506
[TBL] [Abstract][Full Text] [Related]
6. Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
Gauthier N; Lohm S; Touzery C; Chantôme A; Perette B; Reveneau S; Brunotte F; Juillerat-Jeanneret L; Jeannin JF
Carcinogenesis; 2004 Sep; 25(9):1559-65. PubMed ID: 15059928
[TBL] [Abstract][Full Text] [Related]
7. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis.
Wang B; Wei D; Crum VE; Richardson EL; Xiong HH; Luo Y; Huang S; Abbruzzese JL; Xie K
Oncogene; 2003 Mar; 22(12):1771-82. PubMed ID: 12660813
[TBL] [Abstract][Full Text] [Related]
8. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion.
Wang B; Xiong Q; Shi Q; Tan D; Le X; Xie K
Int J Cancer; 2001 Mar; 91(5):607-11. PubMed ID: 11267968
[TBL] [Abstract][Full Text] [Related]
9. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.
Shi Q; Huang S; Jiang W; Kutach LS; Ananthaswamy HN; Xie K
Cancer Res; 1999 May; 59(9):2072-5. PubMed ID: 10232590
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
[TBL] [Abstract][Full Text] [Related]
11. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
[TBL] [Abstract][Full Text] [Related]
12. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
[TBL] [Abstract][Full Text] [Related]
13. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
Stackpole CW
Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
[TBL] [Abstract][Full Text] [Related]
14. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.
Xie K; Huang S; Dong Z; Gutman M; Fidler IJ
Cancer Res; 1995 Jul; 55(14):3123-31. PubMed ID: 7541713
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
[TBL] [Abstract][Full Text] [Related]
17. Direct visualization of nitric oxide release by liver cells after the arrest of metastatic tumor cells in the hepatic microvasculature.
Qi K; Qiu H; Rutherford J; Zhao Y; Nance DM; Orr FW
J Surg Res; 2004 Jun; 119(1):29-35. PubMed ID: 15126078
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
19. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
Talmadge JE; Fidler IJ
J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
[TBL] [Abstract][Full Text] [Related]
20. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells.
Trainer DL; Kline T; Mallon F; Greig R; Poste G
Cancer Res; 1985 Dec; 45(12 Pt 1):6124-30. PubMed ID: 2415238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
